Sign Up
Stories
AI Diagnostic System Regulatory Approval
Share
AI Boosts Household Robot Market
AI Challenges in Healthcare
AI Empowering Household Robot Evolution
2024 Healthcare Quality and AI
AI Challenges in Health Insurance
AI Dilemma in Healthcare
Overview
API
AIM successfully completes regulatory review and device registration for an AI-based endoscopic diagnostic support system in Singapore, aiding in gastric lesion differentiation. AIM aims to expand AI products and target other ASEAN countries with this regulatory approval.
Ask a question
How might the successful regulatory approval of AIM's AI-based diagnostic system impact the healthcare industry in Singapore and other ASEAN countries?
In what ways could the collaboration between AIM and the National University Hospital of Singapore influence the future of AI-based diagnostics in healthcare?
What are the potential implications of AIM's expansion of AI products and targeting other organs, considering the regulatory approval?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage